| Mean rank difference | p value† |
---|
Group 1–1 with 1–2 | − 8.2 | 0.803 |
Group 1–1 with 1–3 | − 16.0 | 0.003** |
Group 1–2 with 1–3 | − 7.8 | 0.997 |
- Group 1–1, which used allograft as a carrier showed a significantly higher bone regeneration rate compared to Group 1–3, which used ACS as a carrier
- Multiple comparisons using rank sums: Bonferroni
- Group 1–1, rhBMP-2 + allograft; Group 1–2, rhBMP-2 xenograft; Group 1–3, rhBMP-2 + ACS
- †p value: adjusted p value (p = 0.05)
- *p < 0.05
- **p < 0.01